Stockscreener 앱 받기
296.51
2.80%
8.09
전일 마감가:
$288.42
열려 있는:
$289.25
하루 거래량:
1.46M
Relative Volume:
0.84
시가총액:
$57.69B
수익:
$328.68B
순이익/손실:
$2.55B
주가수익비율:
22.75
EPS:
13.0349
순현금흐름:
$1.56B
1주 성능:
+3.33%
1개월 성능:
+11.96%
6개월 성능:
-12.50%
1년 성능:
+1.83%
1일 변동 폭
$288.80
$296.83
1주일 범위
$278.51
$296.83
52주 변동 폭
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
296.51 | 55.06B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
786.30 | 88.46B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
238.94 | 55.64B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.43 | 9.51B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.52 | 1.28B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Cencora announces Q3 FY26 earnings release date - scanx.trade
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - FinancialContent
Cencora Inc. focuses on pharmaceutical distribution and healthcare services - AD HOC NEWS
Cencora CubixxCT from Cencora Inc.cold-chain automation for hospital pharmacies - AD HOC NEWS
Form 4 Cencora Inc For: 30 June By Investing.com - Investing.com Canada
Cencora (COR) CFO receives 21,304 restricted stock units vesting through 2029 - Stock Titan
Cencora (COR) CFO files Form 3 showing small direct and trust holdings - Stock Titan
Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase - marketscreener.com
Cencora reports steady business model, shares anchored in US healthcare distribution - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
The Velocity patient support solution from Cencora Inc.integrated care for specialty therapies - AD HOC NEWS
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora operations and strategy, shares reflect ongoing integration of COR acquisition - AD HOC NEWS
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap - Yahoo Finance
Nucleus inventory solution from Cencora Inc.modular cabinets and tighter control for specialty pr - AD HOC NEWS
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO - Yahoo Finance
Cencora revises 2026 outlook, shares underpinned by buyback and analyst support - Ad-hoc-news.de
Knights of Columbus Large Cap Value Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, S&P 500 peer under pressure, shares lag broader healthcare distributors - Ad-hoc-news.de
3 Big Reasons to Love Cencora (COR) - Yahoo Finance
Cencora (COR) Stock After Healthcare Supply Chain Reassessment Is The Market Overreacting - simplywall.st
Price to sales forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora adjusts amid healthcare shifts, shares trade steadily on NYSE - Ad-hoc-news.de
Enterprise value to revenue forward of Cencora, Inc. – LS:766149 - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
AQR Trend Total Return Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, Inc. Actuals & Estimates (NYSE:COR) - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – LS:766149 - TradingView
COR Forecast — Price Target — Prediction for 2027 - TradingView
Cencora analyst targets imply upside, shares in S&P 500 healthcare focus - Ad-hoc-news.de
Cencora raises earnings outlook on share repurchases - MSN
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Price to earnings forward of Cencora, Inc. – NYSE:COR - TradingView
Price to earnings forward of Cencora, Inc. – LS:766149 - TradingView
Centene Corp updates home health strategy, shares tracked against managed care peers - Ad-hoc-news.de
Cencora (COR) Launches Nucleus Pilot And Names A New HR Chief - Sahm
Cencora Inc (COR) Institutional Confidence - TradingKey
Price to book forward of Cencora, Inc. – LS:766149 - TradingView
Insider Buying: Lauren Tyler Acquires Shares of Cencora Inc (COR) - GuruFocus
Are Wall Street analysts bullish on Cencora stock? - MSN
Cencora (COR) director Lauren M. Tyler buys 550 shares in open market - Stock Titan
Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating - Moomoo
BofA Adjusts Price Target on Cencora to $285 From $280 - marketscreener.com
Cencora Inc (COR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
A Look at Cencora Inc (COR) After 3.6% Gain -- GF Value $291.84 vs Price $281.10 - GuruFocus
Cencora insider buying draws attention, shares trade higher on NYSE - Ad-hoc-news.de
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insider Buying: Dermot Durcan Acquires Additional Shares of Cenc - GuruFocus
Jared Moskowitz from Florida’s 23rd District Trades in Cencora and Gilead Sciences Stocks By Investing.com - Investing.com Australia
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cencora Inc 주식 (COR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DURCAN DERMOT MARK | Director |
Jun 18 '26 |
Buy |
274.19 |
4,000 |
1,096,760 |
31,767 |
| DURCAN DERMOT MARK | Director |
May 28 '26 |
Buy |
266.26 |
4,000 |
1,065,040 |
27,767 |
| Battaglia Silvana | Executive Vice President |
Mar 11 '26 |
Option Exercise |
0.00 |
8,415 |
0 |
27,239 |
| Campbell Elizabeth S | Executive Vice President |
Mar 11 '26 |
Option Exercise |
0.00 |
12,623 |
0 |
36,548 |
| Cleary James F | Chief Financial Officer |
Mar 11 '26 |
Option Exercise |
0.00 |
12,623 |
0 |
165,766 |
| Mauch Robert P. | President & CEO |
Feb 20 '26 |
Option Exercise |
86.09 |
3,762 |
323,871 |
69,155 |
| Mauch Robert P. | President & CEO |
Feb 20 '26 |
Sale |
358.94 |
3,762 |
1,350,332 |
65,393 |
| Mauch Robert P. | President & CEO |
Feb 18 '26 |
Sale |
359.46 |
1,333 |
479,160 |
65,393 |
0.51%
자본화:
|
볼륨(24시간):